During this panel, industry in-house counsel and executives will discuss challenges faced by FDA-regulated companies. They will examine the wide breadth of current matters challenging industry, including navigating regulatory uncertainty, changes arising from COVID-19 and moving beyond the pandemic, cybersecurity, enforcement by other agencies, social responsibility, and what they anticipate for the future.
Kenita Barrow, Deputy General Counsel, Legal Affairs, Otsuka America Pharmaceutical, Inc.
Amy Norris, Executive Counsel, Clif Bar and Secretary and General Counsel, FDLI Board of Directors
Steven Przybyla, General Counsel, 22nd Century Group, Inc.
Ami Simunovich, Executive Vice President, Chief Regulatory Officer, BD
Jennifer Zachary, Executive Vice President and General Counsel, Merck & Co., Inc.
Moderated by Freddy Jimenez, Senior Vice President and General Counsel, Celldex Therapeutics, Inc. and Vice Chair, FDLI Board of Directors